ATE412180T1 - Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten - Google Patents

Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten

Info

Publication number
ATE412180T1
ATE412180T1 AT02718225T AT02718225T ATE412180T1 AT E412180 T1 ATE412180 T1 AT E412180T1 AT 02718225 T AT02718225 T AT 02718225T AT 02718225 T AT02718225 T AT 02718225T AT E412180 T1 ATE412180 T1 AT E412180T1
Authority
AT
Austria
Prior art keywords
test
induced diseases
autoantigen
liberated
directed
Prior art date
Application number
AT02718225T
Other languages
English (en)
Inventor
Markku Maeki
Ilma Korponay-Szabo
Original Assignee
Maki Healthtech Oy
Ilma Korponay-Szabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8561063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412180(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Maki Healthtech Oy, Ilma Korponay-Szabo filed Critical Maki Healthtech Oy
Application granted granted Critical
Publication of ATE412180T1 publication Critical patent/ATE412180T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02718225T 2001-04-25 2002-04-24 Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten ATE412180T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Publications (1)

Publication Number Publication Date
ATE412180T1 true ATE412180T1 (de) 2008-11-15

Family

ID=8561063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718225T ATE412180T1 (de) 2001-04-25 2002-04-24 Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten

Country Status (11)

Country Link
US (1) US7361480B2 (de)
EP (1) EP1390753B1 (de)
AT (1) ATE412180T1 (de)
BR (1) BRPI0209172B8 (de)
CA (1) CA2445102C (de)
DE (1) DE60229513D1 (de)
ES (1) ES2314043T3 (de)
FI (1) FI20010868A0 (de)
HU (1) HU229679B1 (de)
PL (1) PL208039B1 (de)
WO (1) WO2002086509A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
GB0117870D0 (en) 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
FR2857453B1 (fr) * 2003-07-11 2007-04-20 Covalab Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe
MX346450B (es) 2008-11-30 2017-03-17 Immusant Inc * Composiciones y métodos para el tratamiento de la enfermedad celíaca.
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
WO2025233646A2 (en) 2024-05-09 2025-11-13 Debreceni Egyetem Detection of celiac disease-specific autoantibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO2001001133A2 (en) 1999-06-28 2001-01-04 Immundiagnostik Ag Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
US6703208B1 (en) * 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Also Published As

Publication number Publication date
PL208039B1 (pl) 2011-03-31
PL366996A1 (en) 2005-02-07
CA2445102A1 (en) 2002-10-31
HU229679B1 (en) 2014-04-28
WO2002086509A8 (en) 2003-01-16
BR0209172A (pt) 2004-08-03
HUP0400066A3 (en) 2006-01-30
WO2002086509A1 (en) 2002-10-31
CA2445102C (en) 2012-01-03
US20040115750A1 (en) 2004-06-17
ES2314043T3 (es) 2009-03-16
US7361480B2 (en) 2008-04-22
BRPI0209172B1 (pt) 2017-06-06
HUP0400066A2 (hu) 2004-04-28
FI20010868A0 (fi) 2001-04-25
DE60229513D1 (de) 2008-12-04
BRPI0209172B8 (pt) 2021-07-27
EP1390753B1 (de) 2008-10-22
EP1390753A2 (de) 2004-02-25

Similar Documents

Publication Publication Date Title
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE438853T1 (de) Diagnostische testvorrichtung
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
WO2006047670A3 (en) Methods for assessing antibodies to neurodegenerative disease-associated antigens
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
WO2006036179A3 (en) Frizzled proteins and detection and treatment of cancer
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE60229513D1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2008060376A3 (en) Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer
ATE427500T1 (de) Hamoglobintest fur neonatales screening
WO2006034328A3 (en) Wnt proteins and detection and treatment of cancer
ATE554388T1 (de) Verfahren und immunabsorbentien zur spezifischen detektion und absorption zöliakie- und dermatitis herpetiformis assoziierter antikörper
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
ATE420365T1 (de) Präparierung von sphären für diagnostische tests
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
WO2004039312A3 (en) Optineurin and glaucoma
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2004016065A3 (es) SISTEMA Y PROCEDIMIENTO INMUNOCROMATOGRÁFICO PARA LA INDENTIFICACIÓN SIMULTÁNEA DE ANTICUERPOS FRENTE A AGA Y t-TG, Y SU USO EN EL DIAGNOSTICO DE ENFERMEDAD CELIACA
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee